These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 18637674)

  • 1. Discovery of novel cathepsin S inhibitors by pharmacophore-based virtual high-throughput screening.
    Markt P; McGoohan C; Walker B; Kirchmair J; Feldmann C; De Martino G; Spitzer G; Distinto S; Schuster D; Wolber G; Laggner C; Langer T
    J Chem Inf Model; 2008 Aug; 48(8):1693-705. PubMed ID: 18637674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual screening of cathepsin k inhibitors using docking and pharmacophore models.
    Ravikumar M; Pavan S; Bairy S; Pramod AB; Sumakanth M; Kishore M; Sumithra T
    Chem Biol Drug Des; 2008 Jul; 72(1):79-90. PubMed ID: 18498326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacophore identification, in silico screening, and virtual library design for inhibitors of the human factor Xa.
    Krovat EM; Frühwirth KH; Langer T
    J Chem Inf Model; 2005; 45(1):146-59. PubMed ID: 15667140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow-binding human serine racemase inhibitors from high-throughput screening of combinatorial libraries.
    Dixon SM; Li P; Liu R; Wolosker H; Lam KS; Kurth MJ; Toney MD
    J Med Chem; 2006 Apr; 49(8):2388-97. PubMed ID: 16610782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystallographic study of inhibitors of tRNA-guanine transglycosylase suggests a new structure-based pharmacophore for virtual screening.
    Brenk R; Meyer EA; Reuter K; Stubbs MT; Garcia GA; Diederich F; Klebe G
    J Mol Biol; 2004 Apr; 338(1):55-75. PubMed ID: 15050823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonpeptidic, noncovalent inhibitors of the cysteine protease cathepsin S.
    Thurmond RL; Beavers MP; Cai H; Meduna SP; Gustin DJ; Sun S; Almond HJ; Karlsson L; Edwards JP
    J Med Chem; 2004 Sep; 47(20):4799-801. PubMed ID: 15369380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
    Mizutani MY; Itai A
    J Med Chem; 2004 Sep; 47(20):4818-28. PubMed ID: 15369385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based virtual screening for identification of novel 11beta-HSD1 inhibitors.
    Yang H; Shen Y; Chen J; Jiang Q; Leng Y; Shen J
    Eur J Med Chem; 2009 Mar; 44(3):1167-71. PubMed ID: 18653260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel non-peptide inhibitors of BACE-1 using virtual high-throughput screening.
    Yi Mok N; Chadwick J; Kellett KA; Hooper NM; Johnson AP; Fishwick CW
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6770-4. PubMed ID: 19854048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for generating less toxic P-selectin inhibitors: pharmacophore modeling, virtual screening and counter pharmacophore screening to remove toxic hits.
    Ananthula RS; Ravikumar M; Pramod AB; Madala KK; Mahmood SK
    J Mol Graph Model; 2008 Nov; 27(4):546-57. PubMed ID: 18993099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scoring ligand similarity in structure-based virtual screening.
    Zavodszky MI; Rohatgi A; Van Voorst JR; Yan H; Kuhn LA
    J Mol Recognit; 2009; 22(4):280-92. PubMed ID: 19235177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of new inhibitors of aldo-keto reductase 1C1 by structure-based virtual screening.
    Brozic P; Turk S; Lanisnik Rizner T; Gobec S
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):245-50. PubMed ID: 18765269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of selective, nonpeptidic nitrile inhibitors of cathepsin s using the substrate activity screening method.
    Patterson AW; Wood WJ; Hornsby M; Lesley S; Spraggon G; Ellman JA
    J Med Chem; 2006 Oct; 49(21):6298-307. PubMed ID: 17034136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of VHR phosphatase inhibitors with micromolar activity based on structure-based virtual screening.
    Park H; Jung SK; Jeong DG; Ryu SE; Kim SJ
    ChemMedChem; 2008 Jun; 3(6):877-80. PubMed ID: 18236492
    [No Abstract]   [Full Text] [Related]  

  • 15. Discovery and SAR studies of a novel series of noncovalent cathepsin S inhibitors.
    Gustin DJ; Sehon CA; Wei J; Cai H; Meduna SP; Khatuya H; Sun S; Gu Y; Jiang W; Thurmond RL; Karlsson L; Edwards JP
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1687-91. PubMed ID: 15745822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening.
    Pérez-Nueno VI; Pettersson S; Ritchie DW; Borrell JI; Teixidó J
    J Chem Inf Model; 2009 Apr; 49(4):810-23. PubMed ID: 19358515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel technologies for virtual screening.
    Lengauer T; Lemmen C; Rarey M; Zimmermann M
    Drug Discov Today; 2004 Jan; 9(1):27-34. PubMed ID: 14761803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based pharmacophore design and virtual screening for novel angiotensin converting enzyme 2 inhibitors.
    Rella M; Rushworth CA; Guy JL; Turner AJ; Langer T; Jackson RM
    J Chem Inf Model; 2006; 46(2):708-16. PubMed ID: 16563001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of fructose-2,6-bisphosphatase inhibitors: a novel virtual screening approach.
    Shaikh MS; Mittal A; Bharatam PV
    J Mol Graph Model; 2008 Feb; 26(6):900-6. PubMed ID: 17644015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate activity screening: a fragment-based method for the rapid identification of nonpeptidic protease inhibitors.
    Wood WJ; Patterson AW; Tsuruoka H; Jain RK; Ellman JA
    J Am Chem Soc; 2005 Nov; 127(44):15521-7. PubMed ID: 16262416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.